Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy Kimball, MD, PhD
University of Maryland Greenebaum Cancer Center
Principal Investigator - Beata Holkova, MD
Massey Cancer Center
Principal Investigator - Nishitha Reddy, MBBS
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Principal Investigator - Sho Ma, MD, PhD
Northwestern University & Robert H Lurie Comprehensive Cancer Center
Principal Investigator - Steven Grant, MD
Virginia Commonwealth University
Study Chair - Thomas C. Shea, MD
UNC Lineberger Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Vanderbilt-Ingram Cancer Center, Vanderbilt University
Nashville, Tennessee, United States
- Virginia Commonwealth University/massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2010
- Primary completion
- 17 Jul 2014
- Completion
- 13 Apr 2018
- Last update posted
- 23 Apr 2018
- Registered enrollment
- 18
- Registry id
- NCT00963274
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.